Results 151 to 160 of about 49,973 (202)
Some of the next articles are maybe not open access.
Progress in Neuro-Psychopharmacology and Biological Psychiatry, 1985
Sixty (60) out-patients with DSM III generalized anxiety disorder were treated after a 1-week placebo washout in a 4-week double-blind study with buspirone, diazepam and placebo; after which they were withdrawn abruptly from medication or assigned to a 2-week period of placebo.
J C, Pecknold +5 more
openaire +2 more sources
Sixty (60) out-patients with DSM III generalized anxiety disorder were treated after a 1-week placebo washout in a 4-week double-blind study with buspirone, diazepam and placebo; after which they were withdrawn abruptly from medication or assigned to a 2-week period of placebo.
J C, Pecknold +5 more
openaire +2 more sources
DeckerMed Psychiatry, 2018
The underlying pathophysiology of anxiety disorders revolve around neurotransmitter transmission, the pharmacologic target of common medication treatments. Pharmacologic treatment of anxiety disorders generally consists of benzodiazepines for short-term relief of anxiety symptoms and antidepressants as a long-term therapy. Benzodiazepines use should be
David A. Beck, Christine L. Beck
+5 more sources
The underlying pathophysiology of anxiety disorders revolve around neurotransmitter transmission, the pharmacologic target of common medication treatments. Pharmacologic treatment of anxiety disorders generally consists of benzodiazepines for short-term relief of anxiety symptoms and antidepressants as a long-term therapy. Benzodiazepines use should be
David A. Beck, Christine L. Beck
+5 more sources
Expert Opinion on Emerging Drugs, 2007
Anxiety disorders are the most common of the psychiatric disorders and are also associated with significant economic costs and impaired work productivity. The first-line pharmacotherapy of pharmatherapy for a number of anxiety disorders comprises selective serotonin re-uptake inhibitors (SSRIs) and serotonin and noradrenaline re-uptake inhibitors ...
Nirvana S, Pillay, Dan J, Stein
openaire +2 more sources
Anxiety disorders are the most common of the psychiatric disorders and are also associated with significant economic costs and impaired work productivity. The first-line pharmacotherapy of pharmatherapy for a number of anxiety disorders comprises selective serotonin re-uptake inhibitors (SSRIs) and serotonin and noradrenaline re-uptake inhibitors ...
Nirvana S, Pillay, Dan J, Stein
openaire +2 more sources
Nihon rinsho. Japanese journal of clinical medicine, 2012
This chapter outlines the clinician' s guide for prescription of benzodiazepine anxiolytics and 5-HT1A receptor agonists. 5-HT1A receptor agonists have entirely different pharmacological mechanism of action from benzodiazepines, and the pattern of their use is quite different from benzodiazepines.
Keiichiro, Tsuji, Osamu, Tajima
openaire +3 more sources
This chapter outlines the clinician' s guide for prescription of benzodiazepine anxiolytics and 5-HT1A receptor agonists. 5-HT1A receptor agonists have entirely different pharmacological mechanism of action from benzodiazepines, and the pattern of their use is quite different from benzodiazepines.
Keiichiro, Tsuji, Osamu, Tajima
openaire +3 more sources
Pharmacology Biochemistry and Behavior
Anxiety disorders are the most prevalent psychiatric pathology with substantial cost to society, but the existing treatments are often inadequate. This has rekindled the interest in the GABAA-receptor (GABAAR) positive allosteric modulator (PAM) compounds, which have a long history in treatment of anxiety beginning with diazepam, chlordiazepoxide, and ...
Rok, Cerne +3 more
openaire +2 more sources
Anxiety disorders are the most prevalent psychiatric pathology with substantial cost to society, but the existing treatments are often inadequate. This has rekindled the interest in the GABAA-receptor (GABAAR) positive allosteric modulator (PAM) compounds, which have a long history in treatment of anxiety beginning with diazepam, chlordiazepoxide, and ...
Rok, Cerne +3 more
openaire +2 more sources
Nihon rinsho. Japanese journal of clinical medicine, 2012
Tsuyoshi, Okamura, Shuichi, Awata
+5 more sources
Tsuyoshi, Okamura, Shuichi, Awata
+5 more sources